Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.

× No keyword cloud information.

5 in total

Review 1. Disease-modifying therapies and infectious risks in multiple sclerosis.

Authors: Alexander Winkelmann; Micha Loebermann; Emil C Reisinger; Hans-Peter Hartung; Uwe K Zettl
Journal: Nat Rev Neurol Date: 2016-03-04 Impact factor: 42.937

2. Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043.

Authors: Rohit Tiwari; Patricia A Miller; Sanghyun Cho; Scott G Franzblau; Marvin J Miller
Journal: ACS Med Chem Lett Date: 2014-11-29 Impact factor: 4.345

3. A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients.

Authors: Agnese Gugliandolo; Federica Longo; Maria Giovanna Marrosu; Giovanni Luigi Mancardi; Ilaria Gandoglia; Maurizio Melis; Fabrizio Lo Giudice; Placido Bramanti; Emanuela Mazzon
Journal: Ther Clin Risk Manag Date: 2018-09-26 Impact factor: 2.423

4. Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review.

Authors: Yuichiro Yasuda; Tatsuya Nagano; Motoko Tachihara; Norio Chihara; Kanoko Umezawa; Naoko Katsurada; Masatsugu Yamamoto; Kenji Sekiguchi; Kazuyuki Kobayashi; Yoshihiro Nishimura
Journal: Ther Clin Risk Manag Date: 2019-11-01 Impact factor: 2.423

5. Pulmonary eosinophilia associated to treatment with natalizumab.

Authors: Elena Curto; Elvira Munteis-Olivas; Eva Balcells; M Marisol Domínguez-Álvarez
Journal: Ann Thorac Med Date: 2016 Jul-Sep Impact factor: 2.219

5 in total